Revance Therapeutics Inc (NASDAQ:RVNC)

27.02
Delayed Data
As of Sep 30
 +1.35 / +5.26%
Today’s Change
11.27
Today|||52-Week Range
29.51
+65.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-73.5M-89.3M-120.6M-142.6M
 
 
 
 
 
Depreciation2.0M1.4M1.5M1.7M
 
 
 
 
 
Total Other Cash Flow13.3M25.2M17.3M13.9M
 
 
 
 
 
Funds From Operations-58.2M-62.6M-101.8M-127.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.5M-2.8M-6.4M-22.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-55.7M-59.8M-95.3M-104.2M
 
 
 
 
 
 
InvestingIncrease In Investments-54.1M-280.7M-36.0M-314.9M
 
 
 
 
 
Decrease In Investments1.1M208.7M157.4M213.4M
 
 
 
 
 
Capital Expenditures-3.3M-1.7M-2.5M-7.0M
 
 
 
 
 
Fixed Asset Disposal--2.0K0.001.5M
 
 
 
Net Assets From Acquisitions 0.00-1.8M-100.0K-100.0K
 
 
 
 
Net Cash Flow Investing-56.3M-75.5M118.8M-107.0M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings9.8M0.000.000.00
 
 
Long Term Debt Reduction-5.3M-3.5M-3.6M-932.0K
 
 
 
 
 
Net Proceeds Stock Sale139.0M1.4M200.2M4.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing------0.00--
Other Uses - Financing993.0K507.0K573.0K2.2M
 
 
 
 
 
Net Cash Flow - Financing142.6M-2.6M195.9M1.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash30.6M-138.0M219.4M-209.5M